Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Kaye

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
European Journal of Cancer Care|June 22, 2018
Treatment patterns and health care resource use in patients receiving multiple lines of therapy for metastatic squamous cell carcinoma of the head and neck in the United KingdomElizabeth M La, Emily Nash Smyth, Sandra E Talbird, et al.
Prostate Cancer|July 30, 2019
Corrigendum to "Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States"Catherine W Saltus, Zdravko P Vassilev, Jihong Zong, et al.
Prostate Cancer|March 20, 2019
Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United StatesCatherine W Saltus, Zdravko P Vassilev, Jihong Zong, et al.
European Journal of Cancer Care|December 29, 2019
Clinical management patterns of advanced and metastatic gastro-oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United KingdomJacqueline Brown, Astra M Liepa, Bela Bapat, et al.
Sarcoma|May 23, 2018
Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United StatesSantiago Zuluaga-Sanchez, Lisa M Hess, Sorrel E Wolowacz, et al.
Lung Cancer (Auckland, N.Z.)|February 27, 2019
Systematic review of sequencing of ALK inhibitors in <i>ALK</i>-positive non-small-cell lung cancerStephanie M Barrows, Kelly Wright, Catherine Copley-Merriman, et al.
Journal of Medical Economics|March 5, 2013
A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropeniaBrian Dulisse, Xiaoyan Li, Julie A Gayle, et al.
BMC Cancer|April 17, 2019
Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysisAdrian D Vickers, Katherine B Winfree, Gebra Cuyun Carter, et al.
Sarcoma|July 7, 2018
Treatment Patterns and Survival among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and FranceSaurabh P Nagar, Daniel S Mytelka, Sean D Candrilli, et al.
Leukemia & Lymphoma|May 10, 2021
Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphomaRavi K Goyal, Preetesh Jain, Saurabh P Nagar, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
European Journal of Cancer Care|June 22, 2018
Treatment patterns and health care resource use in patients receiving multiple lines of therapy for metastatic squamous cell carcinoma of the head and neck in the United KingdomElizabeth M La, Emily Nash Smyth, Sandra E Talbird, et al.
Prostate Cancer|July 30, 2019
Corrigendum to "Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States"Catherine W Saltus, Zdravko P Vassilev, Jihong Zong, et al.
Prostate Cancer|March 20, 2019
Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United StatesCatherine W Saltus, Zdravko P Vassilev, Jihong Zong, et al.
European Journal of Cancer Care|December 29, 2019
Clinical management patterns of advanced and metastatic gastro-oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United KingdomJacqueline Brown, Astra M Liepa, Bela Bapat, et al.
Sarcoma|May 23, 2018
Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United StatesSantiago Zuluaga-Sanchez, Lisa M Hess, Sorrel E Wolowacz, et al.
Lung Cancer (Auckland, N.Z.)|February 27, 2019
Systematic review of sequencing of ALK inhibitors in <i>ALK</i>-positive non-small-cell lung cancerStephanie M Barrows, Kelly Wright, Catherine Copley-Merriman, et al.
Journal of Medical Economics|March 5, 2013
A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropeniaBrian Dulisse, Xiaoyan Li, Julie A Gayle, et al.
BMC Cancer|April 17, 2019
Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysisAdrian D Vickers, Katherine B Winfree, Gebra Cuyun Carter, et al.
Sarcoma|July 7, 2018
Treatment Patterns and Survival among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and FranceSaurabh P Nagar, Daniel S Mytelka, Sean D Candrilli, et al.
Leukemia & Lymphoma|May 10, 2021
Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphomaRavi K Goyal, Preetesh Jain, Saurabh P Nagar, et al.
Pageof 11